The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management.

Source:http://linkedlifedata.com/resource/pubmed/id/8358014

Download in:

View as

General Info

PMID
8358014